Form DEFC14A - Definitive proxy statement, contested solicitations:
SEC Accession No. 0001193125-23-019715
Filing Date
2023-01-31
Accepted
2023-01-31 07:59:59
Documents
3

Document Format Files

Seq Description Document Type Size
1 DEFC14A d424531ddefc14a.htm DEFC14A 234696
2 GRAPHIC g424531g74v25.jpg GRAPHIC 18644
3 GRAPHIC g424531g76b14.jpg GRAPHIC 7700
  Complete submission text file 0001193125-23-019715.txt   273354
Mailing Address SPACES SOUTH DOCKLANDS, BLOCK C 77 SIR JOHN ROGERSON'S QUAY DUBLIN 2 L2 D02 VK60
Business Address SPACES SOUTH DOCKLANDS, BLOCK C 77 SIR JOHN ROGERSON'S QUAY DUBLIN 2 L2 D02 VK60 353 1 6699 020
AMARIN CORP PLC\UK (Filed by) CIK: 0000897448 (see all company filings)

EIN.: 000000000 | State of Incorp.: X0 | Fiscal Year End: 1231
Type: DEFC14A
SIC: 2834 Pharmaceutical Preparations

Mailing Address SPACES SOUTH DOCKLANDS, BLOCK C 77 SIR JOHN ROGERSON'S QUAY DUBLIN 2 L2 D02 VK60
Business Address SPACES SOUTH DOCKLANDS, BLOCK C 77 SIR JOHN ROGERSON'S QUAY DUBLIN 2 L2 D02 VK60 353 1 6699 020
AMARIN CORP PLC\UK (Subject) CIK: 0000897448 (see all company filings)

EIN.: 000000000 | State of Incorp.: X0 | Fiscal Year End: 1231
Type: DEFC14A | Act: 34 | File No.: 000-21392 | Film No.: 23570260
SIC: 2834 Pharmaceutical Preparations